GR3005660T3 - - Google Patents

Info

Publication number
GR3005660T3
GR3005660T3 GR920401983T GR920401983T GR3005660T3 GR 3005660 T3 GR3005660 T3 GR 3005660T3 GR 920401983 T GR920401983 T GR 920401983T GR 920401983 T GR920401983 T GR 920401983T GR 3005660 T3 GR3005660 T3 GR 3005660T3
Authority
GR
Greece
Application number
GR920401983T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868615669A external-priority patent/GB8615669D0/en
Priority claimed from GB868629641A external-priority patent/GB8629641D0/en
Application filed filed Critical
Publication of GR3005660T3 publication Critical patent/GR3005660T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GR920401983T 1986-06-26 1992-09-10 GR3005660T3 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868615669A GB8615669D0 (en) 1986-06-26 1986-06-26 Treatment
GB868629641A GB8629641D0 (en) 1986-12-11 1986-12-11 Treatment

Publications (1)

Publication Number Publication Date
GR3005660T3 true GR3005660T3 (https=) 1993-06-07

Family

ID=26290960

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401983T GR3005660T3 (https=) 1986-06-26 1992-09-10

Country Status (8)

Country Link
US (1) US4790989A (https=)
EP (1) EP0251434B1 (https=)
AU (1) AU600264B2 (https=)
DE (1) DE3780091T2 (https=)
DK (1) DK186087A (https=)
ES (1) ES2041681T3 (https=)
GR (1) GR3005660T3 (https=)
IE (1) IE59628B1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8718886D0 (en) * 1987-08-10 1987-09-16 Ici America Inc Composition
US5279830A (en) * 1990-04-16 1994-01-18 Intellectual Property Holding Co. Mineral oil free and lanolin free cosmetic composition
US5026554A (en) * 1990-09-13 1991-06-25 Merck & Co., Inc. Method of inhibiting fungal growth using squalene synthetase inhibitors
GB9026873D0 (en) * 1990-12-11 1991-01-30 Beecham Group Plc Novel compounds
US5594026A (en) * 1990-12-11 1997-01-14 Smithkline Beecham Group P.L.C. Polymorphs of crystalline mupirocin
DK0727979T3 (da) * 1993-10-22 2001-10-01 Smithkline Beecham Corp Nyt præparat
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
CO4910145A1 (es) * 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
CZ112499A3 (cs) * 1996-10-01 1999-08-11 Smithkline Beecham Corporation Použití mupirocinu k výrobě léčiva pro léčbu bakteriálních infekcí spojených s kolonizací nosohltanu patogenními organismy
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
WO1999007341A1 (en) * 1997-08-09 1999-02-18 Smithkline Beecham Plc Compositions for nasal administration
CA2303443A1 (en) * 1997-09-11 1999-03-18 Anthony Guy Hatton Compositions adapted for prolonged residence in the nasal pharynx
IL123143A (en) * 1998-02-02 2001-08-26 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
GB9808470D0 (en) 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
YU55601A (sh) 1999-02-03 2003-02-28 Biogal Gyogyszergyar Rt. Proces za pripremu antibiotika pseudomonične kiseline a mikrobiološkim metodom
IL137363A (en) * 2000-07-18 2005-12-18 Agis Ind 1983 Ltd Pharmaceutical compositions containing mupirocin
HUP0500797A2 (en) * 2001-06-21 2007-06-28 Biogal Gyogyszergyar Metabolic controlled fermentation process for pseudomonic acid production
CN1625394A (zh) * 2001-12-28 2005-06-08 拜奥盖尔药厂有限公司 结晶和无定形莫匹罗星钙的制备方法
US20040224981A1 (en) * 2003-05-01 2004-11-11 Nebojsa Janjic Antibacterial methods and compositions
US20050123575A1 (en) * 2003-12-03 2005-06-09 Eilon Asculai Spreadable compositions for topical use, an improved process of making same and methods of using same
CA2560984A1 (en) 2004-06-01 2005-12-15 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Process for preparation of amorphous form of a drug
EP2444067A1 (en) 2010-10-20 2012-04-25 Laboratorios Ojer Pharma S.L. Anhydrous gel comprising mupirocin
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
US9868669B2 (en) * 2015-09-25 2018-01-16 Mitsubishi Materials Corporation Precious metal clay regeneration solution and method for regenerating precious metal clay

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3837322A (en) * 1973-07-30 1974-09-24 Honda Motor Co Ltd Carburetor choke
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GB8401965D0 (en) * 1984-01-25 1984-02-29 Beecham Group Plc Composition
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8428952D0 (en) * 1984-11-16 1984-12-27 Beecham Group Plc Formulations

Also Published As

Publication number Publication date
DE3780091D1 (de) 1992-08-06
EP0251434A3 (en) 1988-02-24
AU7132987A (en) 1988-01-07
EP0251434B1 (en) 1992-07-01
IE59628B1 (en) 1994-03-09
IE870889L (en) 1987-12-26
AU600264B2 (en) 1990-08-09
DK186087A (da) 1987-12-27
ES2041681T3 (es) 1993-12-01
DE3780091T2 (de) 1993-02-11
DK186087D0 (da) 1987-04-10
EP0251434A2 (en) 1988-01-07
US4790989A (en) 1988-12-13

Similar Documents

Publication Publication Date Title
IN168664B (https=)
AU7131891A (https=)
GR3005660T3 (https=)
IN164853B (https=)
GR3006907T3 (https=)
DE3790760T1 (https=)
IN170739B (https=)
FR2607948B1 (https=)
JPH0662563B1 (https=)
GR3004369T3 (https=)
GR3006612T3 (https=)
DE3777286D1 (https=)
IN173793B (https=)
AU7131791A (https=)
GB8620171D0 (https=)
IN172283B (https=)
AU5442686A (https=)
IN165999B (https=)
AU5878886A (https=)
IT8603447A1 (it) Apparecchiatura per congiungere al nastro di una bobina in esaurimento il lembo iniziale di una nuova bobina.
BE905521A (https=)
BE905391A (https=)
AU6014586A (https=)
AU5537386A (https=)
BE905236A (https=)